Gilead Sciences Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
6 result(s) found, displaying 1 to 6
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (as fumarate)
-
Prescription medicine registrationActive ingredients: bictegravir (as sodium); tenofovir alafenamide (as fumarate); emtricitabine.
-
Prescription medicine registrationActive ingredients: tenofovir alafenamide fumarate; emtricitabine; elvitegravir; cobicistat.
-
Prescription medicine registrationActive ingredients: sofosbuvir/velpatasvir/voxilaprevir.